Dr. David D. Song, MD, PhD

Dr. Song practices at Arrowhead Regional Medical Center in Colton, California, part of San Bernardino County.

Dr. Song's NPI, 1679599765, was assigned on July 14, 2006. Dr. Song graduated from Tulane School of Medicine in 1992. Dr. Song's California license number on file is A72825.

Dr. Song's primary practice is Arrowhead Regional Medical Center, at 400 North Pepper Avenue, Colton, CA 92324 in San Bernardino County. The practice phone is (909) 580-1000.

Dr. Song's primary practice is Arrowhead Regional Medical Center in Colton, California, part of San Bernardino County. Dr. Song is also affiliated with Riverside Community Hospital. The medical group on file is CUSM Health. Dmand AI also links Dr. Song to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Song practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Song's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Song is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Song's licenses on file in 2 states: California and Colorado.

Dmand AI lists carpal tunnel syndrome, epilepsy, fibromyalgia and chronic pain, hereditary polyneuropathy, lower back pain, migraine and chronic headache, mobility impairment and nerve damage among the conditions Dr. Song treats.

CMS data shows 198 Medicare services from Dr. Song across 5 procedure codes in 2024, for 149 Medicare patients. Medicare paid $20,210 for them.

CMS counts 149 Medicare patients who saw Dr. Song in 2024. The largest group is 65 to 74, with 58 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 42% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Song's median patient age at 57, with 56% women.

In 2024, Dr. Song wrote 1,508 Medicare Part D claims for 169 patients. 91% of them were for generic drugs. CMS names the drug for 1,243 of them, across 30 drugs with 11 or more claims each, at $357,271 in total drug cost. In 2023, CMS named 1,232 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Song for performance year 2024, reported as part of a group. Dr. Song accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Song as offering telehealth. CMS counts 11 procedures of skin biopsy by Dr. Song, more than 59% of the clinicians it reports for that procedure.

Dmand AI links 41 papers to Dr. Song, published from 2006 to 2021. 2013 was the busiest year, with 3. The most frequent topics are Parkinson Disease, Neuropsychological Tests and Analysis of Variance. Dr. Song has published most often in Neuropsychology. Dr. Song's most frequent co-authors are Roland Robert Lee, MD, Stephanie Lorraine Lessig, MD and Irene Litvan, MD.

CMS Open Payments shows 95 general payments to Dr. Song from 25 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 79% of the total. Abbott Laboratories paid the most, $2,023.

Dmand AI lists 6 awards for Dr. Song, most recently CMS Stage 1 EHR in 2013.

Dr. Song graduated from Tulane School of Medicine in 1992. Dr. Song is a member of AAN and MDS.

Dr. Song is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.